Cargando…

Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy

COVID-19, the novel coronavirus pandemic, has already spread around the globe affecting more than 18 million people. As previously observed with other coronaviruses, SARS-CoV-2 deeply dysregulate the immune system eliciting respiratory failure and a state of systemic hyperinflammation in severely il...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torre, Alessandro, Aliberti, Stefano, Castellotti, Paola Francesca, Cirillo, Daniela Maria, Grisolia, Antonella, Mangioni, Davide, Marchetti, Giulia, Rossotti, Roberto, Santus, Pierachille, Besozzi, Giorgio, Villa, Simone, Codecasa, Luigi Ruffo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645275/ https://www.ncbi.nlm.nih.gov/pubmed/33186846 http://dx.doi.org/10.1016/j.rmed.2020.106204

Ejemplares similares

Celebrating TB day at the time of COVID-19
por: Alagna, Riccardo, et al.
Publicado: (2020)

How to improve TB outpatient service in a TB low-endemic country during SARS-CoV-2 pandemic
por: RICCARDI, NICCOLÒ, et al.
Publicado: (2021)

Advantages and Challenges of Tailored Regimens for Drug-Resistant Tuberculosis: A StopTB Italia Look into the Future
por: Riccardi, Niccolò, et al.
Publicado: (2020)

Implementing TB control in a rural, resource-limited setting: the stop-TB Italia project in Senegal
por: Diaw, Mama Moussa, et al.
Publicado: (2018)

IGRA test for TB in COVID-19: role of corticosteroids
por: Granozzi, B., et al.
Publicado: (2022)

First evaluation of the performance of portable IGRA, QIAreach® QuantiFERON®-TB in intermediate TB incidence setting
por: Aziz, Zirwatul Adilah, et al.
Publicado: (2023)

Immunosuppression Adversely Affects TST but Not IGRAs in Patients with Psoriasis or Inflammatory Musculoskeletal Diseases
por: Tavast, Esko, et al.
Publicado: (2012)

A Propensity Score-Matched Study on the Changes of TB Status and TB-IGRA Values in Patients with Psoriasis with Latent TB Receiving Secukinumab
por: Xiao, Yue, et al.
Publicado: (2023)

Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres
por: Riccardi, Niccolò, et al.
Publicado: (2019)

Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting
por: Sharma, Surendra K., et al.
Publicado: (2017)

VIDAS(®) TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
por: Petruccioli, E., et al.
Publicado: (2022)

Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6
por: Ruhwald, Morten, et al.
Publicado: (2017)

Host transcriptional response to TB preventive therapy differentiates two sub-groups of IGRA-positive individuals
por: Broderick, Claire, et al.
Publicado: (2021)

Latent Tuberculosis Infection Treatment Completion while Shifting Prescription from Isoniazid-Only to Rifampicin-Containing Regimens: A Two-Decade Experience in Milan, Italy
por: Villa, Simone, et al.
Publicado: (2019)

Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn’s disease in patients with positive results
por: Zhao, Yujie, et al.
Publicado: (2020)

The association between diabetes status and latent-TB IGRA levels from a cross-sectional study in eastern China
por: Chen, Cheng, et al.
Publicado: (2023)

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis
por: Blasi, Francesco, et al.
Publicado: (2007)

IGRA based diagnosis of infection and prediction of disease
por: Andersen, Peter
Publicado: (2010)

Evaluation of the performance of two tuberculosis interferon gamma release assays (IGRA-ELISA and T-SPOT.TB) for diagnosing Mycobacterium tuberculosis infection
por: Wang, Linchuan, et al.
Publicado: (2018)

CLINICAL APPLICATION OF RT-PCR IN TUBERCULOSIS DNA DETECTION COMBINED WITH TB-IGRA IN THE DIAGNOSIS OF SPUTUM SMEAR-NEGATIVE PULMONARY TUBERCULOSIS
por: Chen, Gao, et al.
Publicado: (2022)

Significant difference in Th1/Th2 paradigm induced by tuberculosis-specific antigens between IGRA-positive and IGRA-negative patients
por: Li, Qiang, et al.
Publicado: (2022)

Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania
por: Jeremiah, Kidola, et al.
Publicado: (2021)

Specificity of a whole blood IGRA in German nursing students
por: Schablon, Anja, et al.
Publicado: (2011)

Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA
por: Jeong, Dae Hyun, et al.
Publicado: (2018)

Sublobar resection: functional evaluation and pathophysiological considerations
por: Santus, Pierachille, et al.
Publicado: (2020)

Repeat IGRA Testing in Canadian Health Workers: Conversions or Unexplained Variability?
por: Zwerling, Alice, et al.
Publicado: (2013)

Activity Disease in SLE Patients Affected IFN-γ in the IGRA Results
por: Maharani, Winni, et al.
Publicado: (2020)

Mucins and Asthma: Are We Headed to the Revolutionary Road?
por: Santus, Pierachille, et al.
Publicado: (2019)

The Challenging Evaluation of Patients with Severe Psoriasis for Latent Tuberculosis: An Important Indication for IGRA
por: Katsenos, Stamatis, et al.
Publicado: (2011)

Tuberculosis screening at the Sainte-Anne Hospital in Paris – results of first and second IGRA
por: Nienhaus, Albert, et al.
Publicado: (2014)

Resistance to TST/IGRA conversion in Uganda: Heritability and Genome-Wide Association Study
por: McHenry, Michael L, et al.
Publicado: (2021)

1871. Lessons Learned from IGRA Test Practices in a Tertiary Hospital
por: Daas, Farah, et al.
Publicado: (2023)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
por: Mantero, Marco, et al.
Publicado: (2018)

The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017)

Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017)

Early consensus management for non-ICU acute respiratory failure SARS-CoV-2 emergency in Italy: from ward to trenches
por: Vitacca, Michele, et al.
Publicado: (2020)

Tuberculosis and pharmacological interactions: A narrative review
por: Riccardi, Niccolò, et al.
Publicado: (2020)

Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study
por: Viecca, Maurizio, et al.
Publicado: (2020)

An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa
por: Kroon, Elouise E., et al.
Publicado: (2020)

IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland
por: Tavast, Esko, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1qv0qtrlkg1sb5abhv26ro6vc0